loadpatents
name:-0.012162923812866
name:-0.0063188076019287
name:-0.008659839630127
MILES; Dillon Harding Patent Filings

MILES; Dillon Harding

Patent Applications and Registrations

Patent applications and USPTO patent grants for MILES; Dillon Harding.The latest application filed is for "processes for preparing aminopyrimidine compounds".

Company Profile
8.7.12
  • MILES; Dillon Harding - Berkeley CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Processes For Preparing Aminopyrimidine Compounds
App 20220235031 - LELETI; Manmohan Reddy ;   et al.
2022-07-28
Inhibitors of CD73-mediated immunosuppression
Grant 11,267,845 - Kalisiak , et al. March 8, 2
2022-03-08
Solid Forms Of A Cd73 Inhibitor And The Use Thereof
App 20220062313 - JEFFREY; Jenna Leigh ;   et al.
2022-03-03
Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders
Grant 11,220,492 - Leleti , et al. January 11, 2
2022-01-11
Modulators Of 5'-nucleotidase, Ecto And The Use Thereof
App 20210371449 - DEBIEN; Laurent Pierre Paul ;   et al.
2021-12-02
Solid Forms Of An Azolopyrimidine Compound
App 20210269422 - Jeffrey; Jenna Leigh ;   et al.
2021-09-02
Quinazoline-pyrazole Derivatives For The Treatment Of Cancer-related Disorders
App 20210214346 - LELETI; Manmohan Reddy ;   et al.
2021-07-15
Inhibitors of adenosine 5'-nucleotidase
Grant 11,058,704 - Debien , et al. July 13, 2
2021-07-13
Quinazoline-pyridine derivatives for the treatment of cancer-related disorders
Grant 11,045,472 - Leleti , et al. June 29, 2
2021-06-29
Pyridone A2r Antagonists
App 20210161898 - LELETI; Manmohan Reddy ;   et al.
2021-06-03
Modulators of 5'-nucleotidase, ecto and the use thereof
Grant 11,001,603 - Debien , et al. May 11, 2
2021-05-11
Modulators of 5'-nucleotidase, ecto and the use thereof
Grant 10,981,944 - Debien , et al. April 20, 2
2021-04-20
Modulators Of 5'-nucleotidase, Ecto And The Use Thereof
App 20210002322 - DEBIEN; Laurent Pierre Paul ;   et al.
2021-01-07
Inhibitors Of Adenosine 5'-nucleotidase
App 20200222441 - DEBIEN; Laurent Pierre Paul ;   et al.
2020-07-16
Quinazoline-pyridine Derivatives For The Treatment Of Cancer-related Disorders
App 20200069689 - LELETI; Manmohan Reddy ;   et al.
2020-03-05
Inhibitors Of Cd73-mediated Immunosuppression
App 20200062797 - KALISIAK; Jaroslaw ;   et al.
2020-02-27
Modulators Of 5'-nucleotidase, Ecto And The Use Thereof
App 20190309010 - DEBIEN; Laurent Pierre Paul ;   et al.
2019-10-10
Modulators of 5'-nucleotidase, ecto and the use thereof
Grant 10,239,912 - Debien , et al.
2019-03-26
Modulators Of 5'-nucleotidase, Ecto And The Use Thereof
App 20170267710 - DEBIEN; Laurent Pierre Paul ;   et al.
2017-09-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed